Effect of the Imera Cultivar Carob in Postprandial Glycemia
IMERACAROBGLUC
Impact of the Imera Carob Cultivar in Postprandial Glycemia
2 other identifiers
interventional
15
1 country
1
Brief Summary
An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
March 26, 2025
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedApril 6, 2025
March 1, 2025
4 months
March 26, 2025
April 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial glucose
Changes in glucose levels after the consumption of the beverage
3 hours
Secondary Outcomes (1)
Postprandial insulin
3 hours
Study Arms (2)
Carob beverage
EXPERIMENTALThe participants consumed a carob beverage prepared with 30 g of Imera cultivar carob powder dissolved in water
Sucrose beverage
ACTIVE COMPARATORThe participants consumed a sucrose beverage made containing 14 g of sugar, matched to the sugar concentration of the experimental beverage
Interventions
The participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water
The participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage
Eligibility Criteria
You may qualify if:
- healthy male adults of normal body fat mass
You may not qualify if:
- obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutrition and Dietetics, HarokopioUniversity of Athens
Kallithea, Attica, 17676, Greece
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 2, 2025
Study Start
January 31, 2024
Primary Completion
May 31, 2024
Study Completion
September 30, 2024
Last Updated
April 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share